Pritesh Shah
2019
In 2019, Pritesh Shah earned a total compensation of $3.6M as Chief Commercial Officer at NovoCure, a 18% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $280,500 |
|---|---|
| Option Awards | $2,027,390 |
| Salary | $425,000 |
| Stock Awards | $867,982 |
| Other | $20,100 |
| Total | $3,620,972 |
Shah received $2M in option awards, accounting for 56% of the total pay in 2019.
Shah also received $280.5K in non-equity incentive plan, $425K in salary, $868K in stock awards and $20.1K in other compensation.
Rankings
In 2019, Pritesh Shah's compensation ranked 3,340th out of 13,971 executives tracked by ExecPay. In other words, Shah earned more than 76.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,340 out of 13,971 | 76th |
Division Manufacturing | 1,209 out of 5,701 | 79th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 164 out of 832 | 80th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 87 out of 535 | 84th |
Industry Surgical and Medical Instruments and Apparatus | 54 out of 350 | 85th |
Source: SEC filing on April 27, 2020.
Shah's colleagues
We found four more compensation records of executives who worked with Pritesh Shah at NovoCure in 2019.